- decreased circulating HDL cholesterol level / IMPC
- increased leukocyte cell number / IMPC
- decreased body weight / IMPC
- decreased circulating serum albumin level / IMPC
- decreased total body fat amount / IMPC
- decreased circulating fructosamine level / IMPC
- preweaning lethality, incomplete penetrance / IMPC
C57BL/6NTac-Dbn1tm1a(KOMP)Wtsi/WtsiFlmg
Status | Available to order |
EMMA ID | EM:13175 |
Citation information | RRID:IMSR_EM:13175 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6NTac-Dbn1tm1a(KOMP)Wtsi/WtsiFlmg |
Alternative name | EPD0211_3_A05 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Dbn1tm1a(KOMP)Wtsi |
Gene/Transgene symbol | Dbn1 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from KOMP ES clone EPD0211_3_A05. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | B.S.R.C. Alexander Fleming, Vari, Greece |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- increased red blood cell distribution width / IMPC
- microcephaly / IMPC
- decreased body weight / IMPC
- increased lean body mass / IMPC
- preweaning lethality, complete penetrance / IMPC
- enlarged heart / IMPC
- increased bone mineral content / IMPC
- decreased total body fat amount / IMPC
- hyperactivity / IMPC
- syndactyly / IMPC
- decreased total retina thickness / IMPC
- abnormal allantois morphology / IMPC
- decreased mean platelet volume / IMPC
- decreased circulating serum albumin level / IMPC
- preweaning lethality, incomplete penetrance / IMPC
- unresponsive to tactile stimuli / IMPC
- abnormal heart morphology / IMPC
- increased CD8-positive, alpha-beta T cell number / IMPC
- decreased circulating fructosamine level / IMPC
- increased leukocyte cell number / IMPC
- decreased grip strength / IMPC
- increased prepulse inhibition / IMPC
- abnormal coat appearance / IMPC
- abnormal embryo turning / IMPC
- abnormal chorioallantoic fusion / IMPC
- increased fasting circulating glucose level / IMPC
- abnormal vertebrae morphology / IMPC
- abnormal embryo size / IMPC
- no spontaneous movement / IMPC
- increased exploration in new environment / IMPC
- increased circulating chloride level / IMPC
- decreased circulating cholesterol level / IMPC
- decreased circulating free fatty acids level / IMPC
- increased circulating phosphate level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased vertical activity / IMPC
- increased circulating magnesium level / IMPC
- abnormal liver morphology / IMPC
- increased circulating creatinine level / IMPC
MGI phenotypes (allele matching)
- decreased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- decreased circulating calcium level / MGI
- decreased body weight / MGI
- decreased mean corpuscular volume / MGI
- decreased circulating alanine transaminase level / MGI
- increased circulating chloride level / MGI
- decreased circulating cholesterol level / MGI
- decreased circulating serum albumin level / MGI
- decreased circulating total protein level / MGI
- decreased circulating aspartate transaminase level / MGI
- decreased total body fat amount / MGI
- decreased circulating fructosamine level / MGI
MGI phenotypes (gene matching)
- decreased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- decreased circulating calcium level / MGI
- enlarged liver sinusoidal spaces / MGI
- abnormal forebrain morphology / MGI
- abnormal telencephalon morphology / MGI
- abnormal hippocampus morphology / MGI
- decreased body weight / MGI
- impaired synaptic plasticity / MGI
- decreased mean corpuscular volume / MGI
- decreased circulating alanine transaminase level / MGI
- no phenotypic analysis / MGI
- increased circulating chloride level / MGI
- decreased circulating cholesterol level / MGI
- decreased circulating serum albumin level / MGI
- decreased circulating total protein level / MGI
- decreased circulating aspartate transaminase level / MGI
- abnormal brain white matter morphology / MGI
- abnormal brain internal capsule morphology / MGI
- abnormal cervical rib / MGI
- impaired cued conditioning behavior / MGI
- abnormal dendritic spine morphology / MGI
- decreased total body fat amount / MGI
- decreased circulating fructosamine level / MGI
- abnormal hypoglossal canal morphology / MGI
- absent hypoglossal canal / MGI
- thin hypoglossal nerve / MGI
- absent hypoglossal nerve / MGI
- abnormal brachial plexus formation / MGI
- abnormal Wolffian duct connection / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).